2025
SJR Q1
JCR Q1 · 3,9
69 matched articles
SCIE
Journal detail
Journal of Vascular Surgery
- Publisher
- Elsevier Inc.
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
0741521410976809
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,728
- Quartile Q1
- H-Index 234
- Cites/doc 3,07
- Docs (3y) 1.490
- Cites (3y) 4.869
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 3,9
- 5Y JIF 4,2
- JCI 1,32
WoS indexes
- SCIE
Subject classification
Categories (SJR)
Areas
WoS categories
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,728 | 3,9 | 4,2 | 1,32 | Q1 | 234 |
| 2024 | Q1 | Q1 | 2,075 | 3,6 | 4,3 | 1,43 | Q1 | 225 |
| 2023 | Q1 | Q1 | 1,936 | 3,9 | 4,3 | 1,39 | Q1 | 225 |
| 2022 | Q1 | Q1 | 2,027 | 4,3 | 4,4 | 1,36 | Q1 | 225 |
| 2021 | Q1 | Q1 | 1,799 | 4,9 | 4,7 | 1,3 | Q1 | 225 |
| 2020 | Q1 | Q1 | 1,939 | 4,3 | 4,4 | 1,16 | Q1 | 225 |
| 2019 | Q1 | Q1 | 1,827 | 3,4 | 3,7 | 1,15 | Q1 | 225 |
| 2018 | — | Q1 | — | 3,2 | 3,6 | 1,14 | Q1 | — |
| 2017 | Q1 | Q1 | 2,308 | 3,3 | 3,5 | 1,19 | Q1 | 225 |
| 2016 | Q1 | Q1 | 2,151 | 3,5 | 3,4 | — | — | 225 |
| 2015 | Q1 | Q1 | 2,189 | 3,5 | 3,3 | — | — | 225 |
| 2014 | Q1 | Q1 | 2,146 | 3 | 3,1 | — | — | 225 |
| 2013 | Q1 | Q1 | 2,079 | 3 | 3,2 | — | — | 225 |
| 2012 | Q1 | Q1 | 2,018 | 2,9 | 3,3 | — | — | 225 |
| 2011 | Q1 | Q1 | 2,051 | 3,2 | 3,7 | — | — | 225 |
| 2010 | Q1 | Q1 | 2,246 | 3,9 | 4 | — | — | 225 |
| 2009 | — | Q1 | — | 3,5 | 3,8 | — | — | — |
| 2008 | — | Q1 | — | 3,8 | 4 | — | — | — |
| 2007 | — | Q1 | — | 3,3 | 3,5 | — | — | — |
| 2006 | — | Q1 | — | 3,3 | — | — | — | — |
| 2005 | — | Q1 | — | 3,2 | — | — | — | — |
| 2004 | — | Q1 | — | 2,7 | — | — | — | — |
| 2003 | — | Q1 | — | 3,5 | — | — | — | — |
| 2002 | — | Q1 | — | 3,5 | — | — | — | — |
| 2001 | — | Q1 | — | 3,1 | — | — | — | — |
| 2000 | — | Q1 | — | 3,1 | — | — | — | — |
| 1999 | — | Q1 | — | 3 | — | — | — | — |
| 1998 | — | Q1 | — | 2,7 | — | — | — | — |
| 1997 | — | Q1 | — | 2,8 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 24/100 |
| 2025 | SURGERY | SCIE | Q1 | Q1 | 34/321 |
| 2024 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 24/98 |
| 2024 | SURGERY | SCIE | Q1 | Q1 | 35/314 |
| 2023 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 17/96 |
| 2023 | SURGERY | SCIE | Q1 | Q1 | 25/292 |
| 2022 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q1 | 25/68 |
| 2022 | SURGERY | SCIE | Q1 | Q1 | 27/213 |
| 2021 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q1 | 22/67 |
| 2021 | SURGERY | SCIE | Q1 | Q1 | 29/213 |
| 2020 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q1 | 20/65 |
| 2020 | SURGERY | SCIE | Q1 | Q1 | 39/211 |
| 2019 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q1 | 20/65 |
| 2019 | SURGERY | SCIE | Q1 | Q1 | 37/210 |
| 2018 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q1 | 21/65 |
| 2018 | SURGERY | SCIE | Q1 | Q1 | 38/203 |
| 2017 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q1 | 20/65 |
| 2017 | SURGERY | SCIE | Q1 | Q1 | 34/200 |
| 2016 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 18/63 |
| 2016 | SURGERY | SCIE | Q1 | — | 30/197 |
| 2015 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 14/63 |
| 2015 | SURGERY | SCIE | Q1 | — | 21/200 |
| 2014 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 21/60 |
| 2014 | SURGERY | SCIE | Q1 | — | 33/198 |
| 2013 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 24/65 |
| 2013 | SURGERY | SCIE | Q1 | — | 30/204 |
| 2012 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 22/68 |
| 2012 | SURGERY | SCIE | Q1 | — | 24/199 |
| 2011 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 17/68 |
| 2011 | SURGERY | SCIE | Q1 | — | 19/199 |
| 2010 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 15/68 |
| 2010 | SURGERY | SCIE | Q1 | — | 10/188 |
| 2009 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 15/61 |
| 2009 | SURGERY | SCIE | Q1 | — | 14/167 |
| 2008 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 13/56 |
| 2008 | SURGERY | SCIE | Q1 | — | 11/148 |
| 2007 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 16/54 |
| 2007 | SURGERY | SCIE | Q1 | — | 13/139 |
| 2006 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 15/52 |
| 2006 | SURGERY | SCIE | Q1 | — | 13/137 |
| 2005 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 15/51 |
| 2005 | SURGERY | SCIE | Q1 | — | 12/139 |
| 2004 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 17/51 |
| 2004 | SURGERY | SCIE | Q1 | — | 14/139 |
| 2003 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 13/52 |
| 2003 | SURGERY | SCIE | Q1 | — | 8/141 |
| 2002 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 10/52 |
| 2002 | SURGERY | SCIE | Q1 | — | 6/141 |
| 2001 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 13/50 |
| 2001 | SURGERY | SCIE | Q1 | — | 7/139 |
| 2000 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 12/45 |
| 2000 | SURGERY | SCIE | Q1 | — | 5/136 |
| 1999 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 11/44 |
| 1999 | SURGERY | SCIE | Q1 | — | 6/131 |
| 1998 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 11/39 |
| 1998 | SURGERY | SCIE | Q1 | — | 8/128 |
| 1997 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 10/38 |
| 1997 | SURGERY | SCIE | Q1 | — | 8/114 |